Cargando…

Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas

This study investigated potential markers for predicting nonfunctioning pituitary adenoma (NFPA) invasion and recurrence by high-throughput tissue microarray analyses. We retrospectively studied two groups of patients: 60 nonrecurrent NFPA cases that included noninvasion and invasion subtypes and 43...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Xiaohui, Zhang, Yazhuo, Wu, Lijuan, Cheng, Rui, Li, Chuzhong, Qu, Chongxiao, Ji, Hongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541973/ https://www.ncbi.nlm.nih.gov/pubmed/31223310 http://dx.doi.org/10.1155/2019/5731639

Ejemplares similares

Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas
por: Yao, Xiaohui, et al.
Publicado: (2017)

Immunohistochemical Profile of Nonfunctioning Pituitary Adenomas
por: Solovey, Mariana, et al.
Publicado: (2021)

Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas
por: Liu, Chunhui, et al.
Publicado: (2016)

A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas
por: Cheng, Sen, et al.
Publicado: (2021)

The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas
por: Zhenye, Li, et al.
Publicado: (2014)

Metabolic Characteristics and M2 Macrophage Infiltrates in Invasive Nonfunctioning Pituitary Adenomas
por: Lin, Kunzhe, et al.
Publicado: (2022)

Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment
por: Wu, Jiangping, et al.
Publicado: (2023)

Nonfunctioning giant pituitary adenomas: Invasiveness and recurrence
por: Landeiro, José Alberto, et al.
Publicado: (2015)

Coexistence of arteriovenous malformation with nonfunctioning pituitary adenoma
por: Yılmaz, Baran, et al.
Publicado: (2015)

Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
por: Takeshita, Kaori, et al.
Publicado: (2022)

Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas
por: Zhan, Xianquan, et al.
Publicado: (2014)

Nonfunctioning Pituitary Adenoma That Changed to a Functional Gonadotropinoma
por: Andino-Ríos, Gerson Geovany, et al.
Publicado: (2018)

Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas
por: Giuffrida, Giuseppe, et al.
Publicado: (2022)

Diagnosis and Treatment of Nonfunctioning Pituitary Adenomas with Thyroid Disorders
por: Wang, Xu, et al.
Publicado: (2023)

Incidental versus symptomatic nonfunctioning pituitary adenomas: Are they different?
por: Guerreiro, Vanessa, et al.
Publicado: (2023)

CDKN2A (p16(INK4A)) affects the anti-tumor effect of CDK inhibitor in somatotroph adenomas
por: Chen, Yiyuan, et al.
Publicado: (2021)

Comparative Efficacy of AZD9496 and Fulvestrant on the Growth of Pituitary Adenoma via Blocking JAK2/STAT5B Pathway
por: Liu, Qian, et al.
Publicado: (2023)

Growth Pattern and Prognostic Factors of Untreated Nonfunctioning Pituitary Adenomas
por: Hwang, Kihwan, et al.
Publicado: (2019)

Neuroendoscopic and microscopic transsphenoidal approach for resection of nonfunctional pituitary adenomas
por: Ding, Zhi-Quan, et al.
Publicado: (2019)

Heart Rate Variability in Postoperative Patients with Nonfunctioning Pituitary Adenoma
por: Ha, Jeonghoon, et al.
Publicado: (2021)

Treatment of Postsurgical Clinically Nonfunctioning Pituitary Adenomas Remnants With Cabergoline
por: Vieira, Marina C M, et al.
Publicado: (2021)

CDK5 and Its Activator P35 in Normal Pituitary and in Pituitary Adenomas: Relationship to VEGF Expression
por: Xie, Weiyan, et al.
Publicado: (2014)

Clinical features and management of nonfunctioning giant pituitary adenomas causing hydrocephalus
por: Zhang, Danfeng, et al.
Publicado: (2018)

Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
por: Yagnik, Garima, et al.
Publicado: (2019)

Free Mucosal Graft for Reconstruction after Nonfunctional Pituitary Adenoma Surgery
por: Pérez-López, Carlos, et al.
Publicado: (2020)

Changes in vascular supply pattern associated with growth of nonfunctioning pituitary adenomas
por: Ito, Miiko, et al.
Publicado: (2022)

Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma
por: Guo, Jing, et al.
Publicado: (2021)

Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
por: Nie, Ding, et al.
Publicado: (2021)

Analysis of the Prognostic and Immunological Role of HSPB1 in Pituitary Adenoma: A Potential Target for Therapy
por: Zhao, Sida, et al.
Publicado: (2023)

Pituitary stone resulting in visual dysfunction and spontaneous rhinorrhea in nonfunctioning pituitary adenoma: illustrative case
por: Kanemitsu, Takuya, et al.
Publicado: (2021)

Emerging role of antiproliferative protein BTG1 and BTG2
por: Kim, Sang Hyeon, et al.
Publicado: (2022)

Alterations of regional homogeneity and functional connectivity in pituitary adenoma patients with visual impairment
por: Song, Guidong, et al.
Publicado: (2017)

The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2019)

Correction: Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
por: Yagnik, Garima, et al.
Publicado: (2019)

BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma
por: Shi, Chengzhang, et al.
Publicado: (2020)

Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?
por: Charleux, Thomas, et al.
Publicado: (2022)

Machine-Learning Prediction of Postoperative Pituitary Hormonal Outcomes in Nonfunctioning Pituitary Adenomas: A Multicenter Study
por: Fang, Yi, et al.
Publicado: (2021)

Tumor suppressors BTG1 and BTG2: Beyond growth control
por: Yuniati, Laurensia, et al.
Publicado: (2018)

Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data
por: Zhao, Peng, et al.
Publicado: (2015)

Corrigendum to “Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data”
por: Zhao, Peng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s6toha4s5e8ilnkspku38c40rh